Startups

This biomanufacturing hub is a star in Philly’s top-tier gene therapy scene

Center for Breakthrough Medicines cofounder Audrey Greenberg spoke to Founding Philly about her org’s growth over the past four years.

Center for Breakthrough Medicines' King of Prussia HQ. (Courtesy Center for Breakthrough Medicines)

Philadelphia is one of the top cell and gene therapy hubs in the US, and Audrey Greenberg is at the forefront.

In 2019, Audrey and her team identified an opportunity to convert a former GSK R&D headquarters in King of Prussia into a biomanufacturing center of excellence.

Center for Breakthrough Medicines (CBM) has since become a leading contract development and manufacturing organization within the region’s burgeoning life sciences community. CMB specializes in cell and gene therapy and partners with pharmaceutical companies to bring their products from the conceptual stage to the market.

Audrey, who is cofounder and chief business officer of CBM, brings extensive experience from her background in accounting, finance, investment banking and private equity. She has played a pivotal role in building the org, focusing on recruiting top talent and securing significant investment, while emphasizing hard work, perseverance, and the importance of establishing trust with clients.

In 2022, SK pharmteco invested $350 million in CBM, and in September, SK announced the acquisition of a controlling interest in CBM. This move adds CBM’s extensive cell and gene therapy expertise to the SK pharmteco portfolio, furthering their strategy to provide end-to-end, multi-modality support for clients.

Tune in to hear Audrey Greenberg discuss her journey in launching CBM and share her insights on the development of cell and gene therapies, the workforce opportunities in Philadelphia, and the impact of broader economic trends on the industry today.

This is a guest post by Founding Philly host Zach Brand. A version of it originally appeared in the podcast's newsletter. It appears here as part of a media partnership between Technical.ly and Founding Philly.
Companies: Center for Breakthrough Medicines

Before you go...

Please consider supporting Technical.ly to keep our independent journalism strong. Unlike most business-focused media outlets, we don’t have a paywall. Instead, we count on your personal and organizational support.

3 ways to support our work:
  • Contribute to the Journalism Fund. Charitable giving ensures our information remains free and accessible for residents to discover workforce programs and entrepreneurship pathways. This includes philanthropic grants and individual tax-deductible donations from readers like you.
  • Use our Preferred Partners. Our directory of vetted providers offers high-quality recommendations for services our readers need, and each referral supports our journalism.
  • Use our services. If you need entrepreneurs and tech leaders to buy your services, are seeking technologists to hire or want more professionals to know about your ecosystem, Technical.ly has the biggest and most engaged audience in the mid-Atlantic. We help companies tell their stories and answer big questions to meet and serve our community.
The journalism fund Preferred partners Our services
Engagement

Join our growing Slack community

Join 5,000 tech professionals and entrepreneurs in our community Slack today!

Trending

Penn dean is a startup founder and ‘engineer at heart’ who loves the connection between education and business

20 tech community events in October you won’t want to miss

A glimpse into Philly’s thriving greentech scene, a bright spot on a national tour

Every startup community wants ‘storytelling.’ Too few are doing anything about it.

Technically Media